Blog Posts

News Alert

Novo to Extend Contract Pharmacy Restrictions to Grantees But Allow Them to Keep Access Under Conditions; Company Also Modifies Hospital Policy

Pharmaceutical manufacturer Novo Nordisk recently announced it will extend its 340B contract pharmacy restrictions to federal grantees.
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Rejects PhRMA’s Request for a Full Panel Rehearing of Arkansas 340B Contract Pharmacy Case

The U.S. 8th Circuit Court of Appeals denied PhRMA's request to reconsider a decision upholding Arkansas' 340B law.
A federal appeals court today rejected a drug industry trade group’s request for all of its appellate judges to reconsider [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Arkansas Enforcing 340B Contract Pharmacy Access Law Against AstraZeneca

Arkansas officials are seeking penalties against AstraZeneca in an August hearing for allegedly violating the state's 340B contract pharmacy access law.
Arkansas state officials today scheduled a public hearing to enforce the state’s 340B contract pharmacy access law against AstraZeneca, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Webinar – It’s a Risky Business: Risk Mitigation and 340B Program Compliance

SPONSORED CONTENT

Attention 340B Covered Entities:  For most covered entities, the 340B program is essential to their organization’s bottom line – so protecting it becomes necessary. 340B program risks are numerous and often not fully recognized. Duplicate discounts, diversion, and poor documentation are common findings from a HRSA audit. People and processes are often insufficient to fully recognize and address compliance risks. At the same time, lawmakers at the federal and state levels are increasing attention on ensuring that providers are good program stewards.

340B program managers should employ multiple strategies to ensure effective risk management programs are in place. Automation and technology tools can enable a comprehensive approach to managing compliance risk. Processes can fail, and people can miss critical compliance elements, but technology mitigates the gaps in risk management.

This webinar will emphasize how non-compliance is not an option, examine the benefit of a proactive compliance approach vs. a reactive one, and

Read More »

Takeda Loosens Contract Pharmacy Restrictions on Arkansas Hospitals

Takeda has loosened its 340B contract pharmacy restrictions for Arkansas-based hospital covered entities.
Editors’ note: After publication, Pfizer became the 24th drugmaker to loosen or end its contract pharmacy restrictions for Arkansas covered entities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Bill Introduced to Expand 340B Eligibility to Outpatient-Focused Rural Emergency Hospitals

Rep. Debbie Dingell (D-Mich.), who sits on the House E&C Committee, co-sponsored legislation that would grant 340B eligibility to certain rural emergency hospitals.
Two federal lawmakers this week introduced bipartisan legislation that would extend 340B eligibility to certain outpatient-focused rural hospitals offering emergency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program Critics, Supporters Target States 

ALEC, a conservative legislative group that receives drug industry funding, is advocating against state 340B legislation. Provider groups have criticized the campaign and launched their own efforts in support of 340B state bills.
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group Critical of Medicare Negotiation and 340B Program Suggests 340B Providers May Avoid IRA Negotiated Lower-Cost Drugs

The American Action Forum published a policy insight that suggested 340B providers could avoid IRA-negotiated lower-cost drugs.
Medicare Part D plans and 340B providers may avoid drugs with negotiated lower Medicare prices to maximize revenue from rebates, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Troy Polan, Chief Information Officer, Avita Care Solutions

Troy Polan

Q: Where did you grow up?

I grew up in southern Connecticut and lived there my entire childhood.

Q: What are your favorites?

Food: Indian, pizza, soft-serve

Read More »

Breaking News

In Victory for Drug Industry, Kansas Legislature Pauses New 340B Contract Pharmacy Law, Sending Issue Back to the Governor

Kansas lawmakers voted late Tuesday for a long-term pause of a recently enacted contract pharmacy law.
Just weeks after passing legislation to prohibit drugmaker 340B contract pharmacy restrictions in the state, Kansas lawmakers voted late Tuesday [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report